Occlude Defect ,
To provide global doctors and patients with safe and innovate medical devices to treat cardiovascular diseases
Being an innovative company, we consistently explore new idea and methods
In January 7, 2018, LifeTech Scientific Corporation has entered into a strategic partnership with Ally Bridge Group (“ABG”), a global healthcare-focused investment firm.
Lifetech Scientific (Shenzhen) Co. Ltd is pleased to announce that its HeartTone™ implantable cardiac pacemaker has been approved by the China Food and Drug Administration (CFDA).
On November 30, 2017, LifeTech (1302:HK) was given the "Best Investment Value Award for Listed Companies for the 13th Five-Year Plan Period" at the seventh session of the China Securities Golden Bauhinia Awards.
On Aug. 20th, 2015, the 伟德国际网址 ASD/PDA/VSD Occluder manufactured by Lifetech got approval in Taiwan, which means these products can be advanced into Taiwan.
On Jane 22th, 2015, SeQure™ snare system of Lifetech got local approval in Brazil, the product is allowed to be sold in Brazil.
On May.6th,2015, CeraFlex™ series of products (including CeraFlex™ ASD Occluder, CeraFlex™PDA Occluder and CeraFlex™ PFO Occluder)and SteerEaseTM of Lifetech got local approval in Saudi Arabia
Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.
Founded in 1999, we are now the second largest provider of congenital heart defect occluders in the world and the largest provider to BRIC countries.